InvestorsHub Logo
Followers 24
Posts 2696
Boards Moderated 0
Alias Born 04/21/2012

Re: None

Monday, 08/12/2013 10:52:51 AM

Monday, August 12, 2013 10:52:51 AM

Post# of 130505
By identifying Retinitis Pigmentosa as an indication for MANF, we have identified a potentially reduced timeline to get MANF to commercialization with a very substantial market opportunity." said Gerald E. Commissiong, CEO of Amarantus